yes,,, I agree the market has had its patience over the years with the management team in RVX. There is no business model evident to exploit speculation from within. I return to the fact that allowing other molecules to sit in limbo for years is a clear sign that this team has no intention to show urgency to the market and investors. That hurts big time imo. If any one of these molecules in wait could save lives we should be ashamed of the team. This company remains to be just a bank for the team. The pitiable share price has been the legacy of DMcC! Misinformation of sorts and the lack of knowing how to capitalize on data has been text book.